DISCOVERY LABORATORIES DEF 14A 10-3-2011

Company

WINDTREE THERAPEUTICS INC /DE/

Filed

August 15, 2011

Period of Report

October 3, 2011

Accession Number

0001140361-11-041646

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →